INSP Inspire Medical Systems Inc

  1. Stocks
  2. Healthcare
  3. NYSE: INSP

Price (delayed)

$125.79

Market cap

$3.74B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.53

Enterprise value

$3.59B

Inspire is a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea. Inspire's proprietary Inspire therapy is the ...

Highlights
INSP's EPS has surged by 65% year-on-year and by 26% since the previous quarter
The net income has soared by 64% YoY and by 26% from the previous quarter
The company's quick ratio fell by 17% YoY
Sector: Healthcare
Industry: Medical Devices
Website: http://www.inspiremedicalsystems.com
Peers: OFIX NVRO

Key stats

What are the main financial stats of INSP
Market
Shares outstanding
29.71M
Market cap
$3.74B
Enterprise value
$3.59B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
6.32
Price to sales (P/S)
5.64
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.43
Earnings
Revenue
$660.91M
EBIT
-$14.05M
EBITDA
-$9.41M
Free cash flow
$3.29M
Per share
EPS
-$0.53
Free cash flow per share
$0.11
Book value per share
$19.91
Revenue per share
$22.32
TBVPS
$23.16
Balance sheet
Total assets
$685.84M
Total liabilities
$96.82M
Debt
$24.5M
Equity
$589.02M
Working capital
$500.04M
Liquidity
Debt to equity
0.04
Current ratio
7.93
Quick ratio
7.12
Net debt/EBITDA
16.04
Margins
EBITDA margin
-1.4%
Gross margin
84.7%
Net margin
-2.4%
Operating margin
-5.4%
Efficiency
Return on assets
-2.4%
Return on equity
-2.8%
Return on invested capital
-4.4%
Return on capital employed
-2.3%
Return on sales
-2.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

INSP stock price

How has the Inspire Medical Systems stock price performed over time
Intraday
-6.86%
1 week
-12.49%
1 month
-8.78%
1 year
-56.15%
YTD
-38.17%
QTD
-6.01%

Financial performance

How have Inspire Medical Systems's revenue and profit performed over time
Revenue
$660.91M
Gross profit
$559.47M
Operating income
-$35.99M
Net income
-$15.73M
Gross margin
84.7%
Net margin
-2.4%
INSP's net margin has soared by 74% YoY and by 29% QoQ
The net income has soared by 64% YoY and by 26% from the previous quarter
The operating margin has soared by 50% YoY and by 16% from the previous quarter
The gross profit has grown by 43% YoY and by 6% from the previous quarter

Growth

What is Inspire Medical Systems's growth rate over time

Valuation

What is Inspire Medical Systems stock price valuation
P/E
N/A
P/B
6.32
P/S
5.64
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.43
INSP's EPS has surged by 65% year-on-year and by 26% since the previous quarter
The P/B is 61% below the 5-year quarterly average of 17.3 and 46% below the last 4 quarters average of 12.5
The company's equity rose by 17% YoY and by 2.9% QoQ
The stock's P/S is 73% less than its 5-year quarterly average of 22.8 and 49% less than its last 4 quarters average of 11.9
Inspire Medical Systems's revenue has increased by 42% YoY and by 6% from the previous quarter

Efficiency

How efficient is Inspire Medical Systems business performance
INSP's ROIC has soared by 92% YoY and by 51% from the previous quarter
INSP's return on sales has surged by 76% year-on-year and by 34% since the previous quarter
INSP's ROE has soared by 73% year-on-year and by 28% since the previous quarter
INSP's ROA has soared by 73% YoY and by 29% from the previous quarter

Dividends

What is INSP's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for INSP.

Financial health

How did Inspire Medical Systems financials performed over time
The total liabilities is up by 44% YoY but it is down by 7% from the previous quarter
The company's total assets rose by 20% YoY
INSP's debt is 96% lower than its equity
The company's equity rose by 17% YoY and by 2.9% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.